Mutational signature-based classification of ampullary carcinoma
Erman Akkus, Medical oncology fellow at the Ankara University, shared a recent article by Ekaterina Zhuravleva on X:
“Mutational signature-based classification of ampullary carcinoma in Gut Journal.
Cluster 1-2: want pathway.
Cluster 3: Immunogenic (better sırvival).
ICIs and want pathway-targeted therapies.”
Title: Mutational signatures define immune and Wnt-associated subtypes of ampullary carcinoma
Authors: Ekaterina Zhuravleva, Monika Lewinska, Colm J O’Rourke, Antonio Pea, Asif Rashid, Ann W Hsing, Andrzej Taranta, David Chang, Yu-Tang Gao, Jill Koshiol, Rui Caetano Oliveira and Jesper B Andersen
Erman Akkus is a medical oncology fellow at the Ankara University, Faculty of Medicine. Previously, he was an Internal Medicine Resident at the Ankara University, Faculty of Medicine. He was also a Visiting Researcher at the University of Oslo. He completed his education from the Medical University of Vienna.
More posts featuring Erman Akkus.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023